jhonny peralta getty

Let’s pump the brakes on the “PED use got Jhonny Peralta his big deal” talk


With a respectful nod to Ken Rosenthal, our own Bill Baer and the players who have taken to Twitter in the past couple of days to talk about Jhonny Peralta, may I ask why everyone seems to think that Peralta’s new contract represents some sort of problem with the drug penalty system in baseball and the incentives that flow therefrom? Because from where I’m sitting, it’s way more complicated than that.

I get the superficial appeal of the argument that goes “Peralta got busted for PEDs and then he gets a four-year, $52 million deal. What’s up with that?!” But that argument totally ignores the nature of the current free agent market to begin with.

Here’s a shocking idea: Jhonny Peralta got a big crazy free agent contract, not because he used PEDs, thereby messing up the incentive system, but because everyone in free agency is getting a big crazy free agent contract these days.

Those shaking their heads at Peralta say things like “clearly the current drug penalties are not hurting players’ market value.” But if you swap in phrases like “being hurt,” “being average” or “severely underperforming expectations” for “the current drug penalties” it explains current reality too. Dan Haren is coming off two injury-plagued and often ineffective years and he got $10 million. Jason Vargas got four-years, $32 million as a back-of-the-rotation starter. Tim Hudson has been pretty bad and got two-years, $23 million. Carlos Ruiz got three-years, $26 million. Why isn’t anyone talking about how their deals are confounding the incentive system that’s supposed to be in place?

Probably because they’re not. They’re getting what the market — currently flush with billions of dollars in new broadcast dollars and vanishingly small ways for teams to spend money on amateur and international signings — allows. Look around at the crop of shortstop talent in Major League Baseball at the moment and tell me that talent isn’t hard to come by. Then tell me that Peralta’s deal has more to do with him being a PED user than him simply being a good shortstop in a weak shortstop market who happened to hit free agency at the right time.

The fact that a team — a smart team, by the way — is spending serious money on Jhonny Peralta right now is because he’s in the market. Increase the ban to 100 games? Sure, maybe that would work for a guy whose ban coincided with his free agency, but it doesn’t always, or even often, work that way. Say a guy gets a ban in the second year of his three year deal, comes back in year three and plays well prior to becoming a free agent. Say a player tests positive in the spring of his walk year, serves his 100 games and then comes back in late July and lights it up just before free agency. You think those guys are not going to get paid the following offseason? Of course they are. Because they’ll be active players with marketable skills and teams like to give those guys lots of money.

The only way totally eliminate the idea of guys who take PEDs from later getting paid is to give permanent bans for first offenses. But of course that’s crazy. It’d be an ultra-extreme response to a problem that no one has demonstrated calls for such a solution and which would likely end the careers of some players based on false positives or inadvertent ingestion of PEDs. And no one who grouses about Jhonny Peralta allegedly screwing with the incentive system would ever seriously make that argument, would they? I seriously doubt it.

Peralta got paid because he’s a good player at a position with scant available talent in a market that is paying through the nose for even ordinary talent. If that’s troublesome to you, you have a lot of things to worry about besides whether 50-game suspensions are sufficient to deter PED use.

Royals hold on to beat Astros, even up ALDS at 1-1

Alcides Escobar
AP Photo

The Royals kept their foot on the pedal, rallying late to take down the Astros in Game 2 of the ALDS by a 5-4 score. The series is now evened up at one game apiece in the best-of-five series.

Ben Zobrist broke a 4-4 tie in the bottom of the seventh, ripping a single to left field to plate Alcides Escobar, who had led off the inning with a triple to right-center.

The Royals were down 3-0 after the first two innings and 4-2 after three. Astros outfielder Colby Rasmus accounted for two of the runs with an RBI double in the first inning and a solo homer in the third. Catcher Salvador Perez opened up the scoring for the Royals with a solo homer in the second.

Royals starter Johnny Cueto started off poorly but was able to rebound in the latter half of his six innings. Overall, he gave up four runs on seven hits and three walks with five strikeouts. Relievers Kelvin Herrera, Ryan Madson, and Wade Davis each pitched a scoreless inning behind Cueto to seal the deal. Davis benefited from replay review to secure the second out of the ninth inning, picking off pinch-runner Carlos Gomez at first base. He replaced Preston Tucker, who had walked with one out.

For the Astros, starter Scott Kazmir wasn’t able to escape the sixth inning, leaving with one out in the frame. He ultimately allowed three runs on five hits and a walk with four strikeouts. Lefty reliever Oliver Perez came in after Kazmir, but gave up two singles and a walk as his inherited runner scored. Josh Fields relieved Perez and allowed one of Perez’s runners to score on a bases-loaded walk.

The Royals are the first home team to win so far this post-season. The visiting Rangers beat the Blue Jays in both ALDS games played thus far, while the visiting Astros and Cubs both won in the Wild Card games.

The two squads will travel to Houston. Game 3 resumes on Sunday at 4:00 PM EDT with Dallas Keuchel taking the hill for the Astros and Edison Volquez toeing the slab for the Royals.

Cardinals take early 1-0 lead over the Cubs in Game 1 of the NLDS

Matt Holliday
AP Photo

Cardinals outfielder Matt Holliday staked his team to an early 1-0 lead with an RBI single in the first inning of Game 1 of the NLDS against the Cubs. Rookie Stephen Piscotty had doubled with one out against Cubs starter Jon Lester, putting himself in scoring position ahead of Holliday’s single.

Starter John Lackey tossed a scoreless top of the first inning and reprised the performance in the top of the second, so the Cardinals have a small lead to open up their post-season.

Holliday, 35, posted an .804 OPS during the season but missed a significant amount of time in the second half due to a Grade 2 strain of his right quadriceps.

Video: Rougned Odor gets the benefit of the doubt upon replay review

Rougned Odor
The Associated Press

Rangers second baseman Rougned Odor appeared to luck out when a replay review was upheld in the 14th inning, ruling Odor safe at second base. Odor had beaten out an infield single to put the go-ahead run on base in a 4-4 game, then scampered to second base on Chris Jimenez’s single to right field.

Odor rounded the second base bag a little too hard and had to retreat quickly as Jose Bautista fired a laser to shortstop Troy Tulowitzki. To the naked eye, Odor appeared to barely get back in safely, but replays showed Odor’s foot coming off of the bag following initial contact as Tulowitzki applied the tag. The initial safe call was upheld as there ostensibly wasn’t overwhelming evidence upon which to base a decision to overturn.

The call would immediately prove important, as Odor came in to score the go-ahead run when Hanser Albert ripped a single to center field. The Rangers took a 5-4 lead in the game and would tack on one more before the frame was over, helping them move to a 2-0 AL Division Series lead over the Blue Jays.